home / stock / asp:cc / asp:cc news

ASP:CC News and Press, Acerus Pharmaceuticals Corporation From 08/23/22

Stock Information
Company Name: Acerus Pharmaceuticals Corporation
Stock Symbol: ASP:CC
Market: TSXC
Website: aceruspharma.com
Menu
ASP:CC ASP:CC Quote ASP:CC Short ASP:CC News ASP:CC Articles ASP:CC Message Board
Get ASP:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
ASP:CC - Acerus Announces Resignation of CFO Effective November 20, 2022

TORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX:ASP; OTCQB:ASPCF) today announced that Robert Motz has informed the Company of his decision to resign as Chief Financial Officer effective N...
ASP:CC - Acerus Announces Amendments to Loan Facility and Promissory Note Due to Former Serenity Shareholders

TORONTO, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX:ASP; OTCQB:ASPCF) today announced that it has entered into an amending agreement with First Generation Capital Inc. (“ First Genera...

ASP:CC - Acerus to Report Q2-2022 Financial Results and Host Investor Call

TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2022 financial and operating results on Tuesday, August 9, 2022 before the market opens. The company will also host a conference call on Tuesday, August 9, 2...

ASP:CC - Acerus Announces Voting Results for the 2022 Annual Meeting

TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“ Acerus ”) (TSX: ASP; OTCQB: ASPCF) today announced the voting results from its annual meeting of shareholders held on June 27, 2022. The total number of shares represented in person or by prox...
ASP:CC - Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders

TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX:ASP; OTCQB:ASPCD) today announced that it has entered into an amended and restated promissory note (the “ A&R Note ”) ...

ASP:CC - Acerus Reports First Quarter 2022 Financial Results

TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three-month period ended March 31, 2022. Unless otherwise noted, all amounts are in US d...

ASP:CC - Acerus To Report Q1-2022 Financial Results And Host Investor Call

TORONTO, May 05, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCD) will announce its first quarter 2022 financial and operating results on Tuesday, May 10, 2022 before the market opens. The company will also host a conference call on Tuesday, May 10, 2022 at...
ASP:CC - Acerus Announces Completion of Share Consolidation

TORONTO, April 26, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) announced that further to its news release from April 19, 2022, the Company’s application to consolidate its common shares (&#...

ASP:CC - Acerus Announces Share Consolidation

TORONTO, April 19, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that the Company intends to undertake a consolidation of its outstanding common shares on the basis of one (1) post-c...

ASP:CC - Acerus Announces Amendments to Loan Facility

TORONTO, March 31, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX:ASP; OTCQB:ASPCF) today announced that it has entered into an amending agreement with First Generation Capital Inc. (“ First Gener...
Previous 10 Next 10